Ivan Chen - 20 Aug 2024 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
Director
Signature
/s/ Ivan Chen
Issuer symbol
PURE
Transactions as of
20 Aug 2024
Net transactions value
$0
Form type
4
Filing time
22 Aug 2024, 17:56:02 UTC
Previous filing
03 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 20 Aug 2024 Common Stock 150,000 $0.0700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of January 15, 2025 or the date of the Issuer's annual meeting of stockholders held in 2025, and (ii) 50% of the options will vest on the earlier of January 15, 2026 or the date of the Issuer's annual meeting of stockholders held in 2026.